Our network spans community and specialist clinical settings, providing access to patient populations across a broad range of therapeutic areas, from common chronic conditions to specialist indications.
The therapeutic areas listed below reflect the clinical backgrounds of our investigator network and the patient populations present across our sites. If your indication is not listed, contact us. We may still be able to assist.
Hypertension, heart failure, atrial fibrillation, dyslipidaemia, and atherosclerosis. Strong patient populations across community GP sites.
Type 2 diabetes, obesity, NASH/NAFLD, thyroid disease, and metabolic syndrome. High prevalence in community clinic populations.
Major depressive disorder, generalised anxiety disorder, migraine, insomnia, and early-stage neurodegenerative conditions.
Asthma, COPD, allergic rhinitis, and emerging biologics for eosinophilic and type 2 inflammatory disease.
Rheumatoid arthritis, psoriasis, inflammatory bowel disease, and other autoimmune conditions. Access to community and specialist referral networks.
Vaccine trials, antiviral research, and post-infectious syndromes. Community GP sites are well-positioned for vaccine cohort recruitment.
Contraception, menopause, osteoporosis, and gynaecological conditions. GP network provides direct access to relevant patient populations.
Atopic dermatitis, psoriasis, acne, and other inflammatory skin conditions. Community access facilitates broad patient identification.
Selected Phase II studies in solid tumours and haematological malignancies, in collaboration with specialist oncology partners. Contact us to discuss suitability.
Our network is growing. Contact us to discuss whether we can support your therapeutic area, even if it is not listed above.